Key facts
- This page summarizes Daniel Sullivan's Form 4 filing for EDGEWELL PERSONAL CARE Co (EPC).
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 16 Nov 2021, 13:00.
Daniel Sullivan - 12 Nov 2021 Form 4 Insider Report for EDGEWELL PERSONAL CARE Co (EPC)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- EPC
- Reported as of
- 12 Nov 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Nov 2021, 13:00:35 UTC
- Prior SEC filing
- 12 Nov 2021
- Next SEC filing
- 17 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- Marisa Iasenza, Attorney in Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daniel Sullivan filed Form 4 for EDGEWELL PERSONAL CARE Co (EPC) on 16 Nov 2021.
Change
- Previous filing in this sequence was filed on 12 Nov 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EPC
transaction
Derivative
Non-Qualified Stock Options 11/12/2021
Award
- Transaction value
- $0
- Shares
- +16,428
- Change %
- Price
- $0.000000
- Shares after
- 16,428
- Date
- 12 Nov 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,428
- Exercise price
- $43.29
- Footnotes
- F1
EPC
transaction
Derivative
Restricted Stock Equivalents (RSE) 11/12/2021
Award
- Transaction value
- $0
- Shares
- +8,317
- Change %
- Price
- $0.000000
- Shares after
- 8,317
- Date
- 12 Nov 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,317
- Exercise price
- $0.000000
- Footnotes
- F2
EPC
transaction
Derivative
Performance Restricted Stock Equivalents (PRSE) 11/12/2021
Award
- Transaction value
- $0
- Shares
- +27,721
- Change %
- Price
- $0.000000
- Shares after
- 27,721
- Date
- 12 Nov 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 27,721
- Exercise price
- $0.000000
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
One-third of the Options will become exercisable on each of 11/12/2022, 11/12/2023 and 11/12/2024, as long as the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events.
Footnote F2
One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/12/2022, 11/12/2023 and 11/12/2024 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events.
Footnote F3
The PRSEs will vest and convert into shares of Edgewell common stock on the date that Edgewell releases its earnings for the fiscal year ending September 30, 2024 if the following specified performance criteria is met: Relative Total Shareholder Return for the "Performance Period" beginning on October 1, 2021 and ending on September 30, 2024 (100%). Percentage will range from 0% to 100% based on company performance. The amount shown is the maximum amount available to vest.